COURTNEY JOAN GEMMATO, M.D.

Plain English
Researchers replaced the hearts of eight calves with mechanical pumps that provide continuous, smooth blood flow (rather than the natural heartbeat's pulsing action) and kept the animals alive for an average of nearly 60 days. Blood tests, organ function markers, and tissue examinations showed that the calves' organs remained healthy throughout this period, and several calves could even exercise on a treadmill. This proves that a completely artificial heart using this continuous-flow technology can work long-term without damaging the body's organs, opening the door to developing this technology for humans who need heart transplants.

Plain English
Researchers discovered that six patients with mechanical heart pump devices (which continuously push blood without creating a pulse) developed a dangerous heart rhythm called ventricular fibrillation but remained conscious, alert, and stable without treatment. This happened because the continuous-flow pump was doing the heart's job so effectively that the heart's irregular beating didn't cause a medical crisis. This finding matters because it suggests doctors may need to rethink when and how to treat this heart rhythm in patients with these devices, since the standard emergency treatment (electric shock) might not be necessary.

Plain English
This research paper looks at the challenges of using mechanical circulatory support (MCS) devices for children with heart failure. Unlike adults, who have a variety of device options, pediatric patients often face limitations because the devices must be smaller and designed for their unique health needs. This means specialized care teams, particularly nurses, must understand both the child's condition and the MCS systems to provide the best support. Who this helps: This helps pediatric patients with heart failure and the healthcare teams caring for them.

Plain English
This study examined a serious issue that can occur during heart surgery: air getting into the bloodstream, known as air embolism. A 45-year-old patient with a heart assist device faced this problem when a lot of air entered his system during surgery. The medical team acted quickly, using various techniques, and after 5 days in a coma and physical therapy, the patient improved significantly; he left the hospital 44 days later with only mild weakness on one side of his body. Who this helps: This helps patients undergoing heart pump surgeries and the doctors treating them.

Plain English
This study looked at the long-term effects of the HeartWare HVAD, a device used to assist heart function, in 6 healthy sheep over a 90-day period. The results showed that the device worked well without causing major problems—most blood and organ tests were normal, and the device had no significant failures, although two sheep had minor kidney issues. This is important because it suggests the HeartWare HVAD may be a safe and effective option for patients needing heart support. Who this helps: Patients with heart failure who may need mechanical support.

Plain English
This study looked at how well the TandemHeart device works to help patients who are experiencing severe heart problems or are undergoing risky heart procedures. It was used on 18 patients, and those with heart failure got support for an average of nearly 89 hours, improving heart function significantly from a score of 1.57 to 2.60. Overall, 61% of the patients survived 30 days after using the device, showing it can be an effective temporary solution for heart support. Who this helps: This helps patients with severe heart issues and doctors managing high-risk cardiac procedures.

Plain English
This study looked at how the Texas Heart Institute has been using mechanical devices to assist the heart since the 1960s, including options like pumps and artificial hearts. Over 35 years, they have gathered extensive experience with these devices, helping patients who need temporary or permanent heart support. This research is important because it shows the progress and effectiveness of these life-saving technologies. Who this helps: Patients with severe heart problems.